[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100361080":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":10,"centralContacts":24,"locations":34,"responsibleParty":57,"collaborators":10,"id":60,"slug":10,"hasResults":61,"nctId":62,"briefTitle":63,"officialTitle":64,"acronym":10,"eligibilityCriteria":65,"healthyVolunteers":61,"sex":66,"minAge":67,"maxAge":10,"enrollmentInfo":68,"targetDuration":10,"studyType":71,"phases":10,"briefSummary":72,"conditions":73,"keywords":78,"overallStatus":37,"whyStopped":10,"lastUpdateSubmitDate":80,"lastUpdatePostDateStruct":81,"startDateStruct":84,"completionDateStruct":86,"leadSponsor":88,"locationsCount":89},{"fullName":5,"class":6},"IRCCS San Raffaele","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Small Renal Tumors",null,"Subjects with small renal tumors (SRT) ad described by current ESMO (European Society for Medical Oncology) guidelines who are candidates for MWA",[13],"Procedure: Microwave ablation (MWA)",{"label":15,"type":10,"description":16,"interventionNames":17},"Primary and Secondary Liver cancer","Primary liver tumors: subjects who are candidates for MWA with nodules ≤ 3 cm Liver metastases: subjects who are candidates for MWA with nodules less than ≤ 3 cm",[13],[19],{"type":20,"name":21,"description":22,"armGroupLabels":23,"otherNames":10},"PROCEDURE","Microwave ablation (MWA)","Thermal ablation",[15,9],[25,30],{"name":26,"role":27,"phone":28,"phoneExt":10,"email":29},"Francesco De Cobelli, MD","CONTACT","+390226432529","decobelli.francesco@hsr.it",{"name":31,"role":27,"phone":32,"phoneExt":10,"email":33},"Stephanie Steidler, PhD","+3926432529","steidler.stephanie@hsr.it",[35],{"facility":36,"status":37,"city":38,"state":10,"zip":39,"country":40,"countryCode":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"IRCCS Ospedale San Raffaele","RECRUITING","Milan","20153","Italy","IT",{"type":43,"coordinates":44},"Point",[45,46],12.59836,42.78235,{"lat":46,"lon":45},[49,51,52,55],{"name":50,"role":27,"phone":10,"phoneExt":10,"email":29},"Francesco De Cobelli",{"name":31,"role":27,"phone":28,"phoneExt":10,"email":33},{"name":53,"role":54,"phone":10,"phoneExt":10,"email":10},"Paolo Marra, MD","SUB_INVESTIGATOR",{"name":56,"role":54,"phone":10,"phoneExt":10,"email":10},"Michele Colombo, MD",{"type":58,"investigatorFullName":50,"investigatorTitle":59,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"SPONSOR_INVESTIGATOR","Professor of Radiology, Clinical and Experimental Radiology","100361080",false,"NCT03981497","Microwave Ablation for Treatment of Small Renal Tumors and Primary and Secondary Liver Neoplasms","Retrospective and Perspective Analysis of Short, Medium and Long Term Clinical Performance of Patients Undergoing MicrowaveThermal Ablation for Treatment of Small Renal Tumors and Primary and Secondary Liver Neoplasms","Inclusion Criteria:\n\n* \\> 18 years with primary or secondary liver tumors or small kidney tumors that are not candidates for surgery or cannot be radically resected by surgery alone\n* Primary liver cancer: up to three liver nodules ≤ 3 cm\n* Secondary hepatic tumours: up to nodules ≤ 3 cm provided that the objective is complete hepatic clearance Renal tumours: single or multiple (von Hippel Lindau syndrome), \\\u003C 4 cm\n\nExclusion Criteria:\n\n* pregnant women\n* non-manageable coagulopathies\n* Extended extrahepatic or extrarenal disease\n* for liver ablation: presence of bilio-digestive anastomosis","ALL","18 Years",{"count":69,"type":70},500,"ESTIMATED","OBSERVATIONAL","The goal of this observational study is to collect data on efficacy and safety of microwave ablation (MWA) used to treat subjects with primary and secondary liver malignancies and renal malignancies. The main question it aims to evaluate the short, medium and long-term clinical course of patients treated with MWA.\n\nParticipants will not alter their normal clinical and therapeutic practice, due to the observational nature of the study, and all data regarding microwave treatments will be collected (including demographic data). follow their normal clinical and therapeutic path",[74,75,76,77],"Liver Cancer","Liver Metastasis Colon Cancer","Kidney Cancer","Renal Cell Carcinoma",[79],"MWA","2024-04-11",{"date":82,"type":83},"2024-04-12","ACTUAL",{"date":85,"type":83},"2018-02-28",{"date":87,"type":70},"2030-12-31",{"name":50,"class":6},1]